Nationwide Fund Advisors’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Nationwide Fund Advisors’s Portfolio CVRS Stock Details CVRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-47,426	Closed	-$72K	–	2763
2017 Q3	$72K	Hold	47,426	–	–	﹤0.01%	2991
2017 Q2	$88K	Buy	47,426 +15,979	+51%	+$21.3K	﹤0.01%	2954
2017 Q1	$41K	Hold	31,447	–	–	﹤0.01%	3014
2016 Q4	$22K	Hold	31,447	–	–	﹤0.01%	3083
2016 Q3	$35K	Hold	31,447	–	–	﹤0.01%	3088
2016 Q2	$45K	Buy	31,447 +17,455	+125%	+$20.2K	﹤0.01%	3090
2016 Q1	$14K	Hold	13,992	–	–	﹤0.01%	3125
2015 Q4	$45K	Hold	13,992	–	–	﹤0.01%	3009
2015 Q3	$43K	Hold	13,992	–	–	﹤0.01%	3044
2015 Q2	$49K	Buy	+13,992	New	+$59.7K	﹤0.01%	3104

Other funds holding CVRS

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nationwide Fund Advisors's CVRS Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2017, closing a stake of 47,426 shares — an estimated $72K sold.

Nationwide Fund Advisors first reported a position in CVRS in Q2 2015 and held it in 10 quarters. The position peaked at $88K in Q2 2017. 64 funds tracked by Wall St. Rank hold CVRS as of Q4 2017.

Nationwide Fund Advisors reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 47,426 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2017, an estimated $72K.
Nationwide Fund Advisors first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2015 and held it in 10 quarters.
Nationwide Fund Advisors's CORINDUS VASCULAR ROBOTICS, INC position peaked at $88K in Q2 2017.
64 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.